|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.650 USD | -0.60% |
|
+3.12% | +10.74% |
| 11-14 | Marker Therapeutics Q3 net loss narrows to $2 mln | RE |
| 11-13 | Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
Trading Ideas
Search
No results for this search
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Trading Ideas
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition